respiratory
Bronchitis

No evidence for Beta2-agonists in acute bronchitis: Cochrane


There is no evidence to support the use of beta2-agonists in children and adults with acute cough who do not have evidence of airflow restriction, a Cochrane review concludes. The analysis of seven trials by Cochrane Acute Respiratory Infections Group noted that treatment might reduce symptoms, including cough. However the potential benefits were not well ...

Already a member?

Enter your email to keep reading.


OR